WLan Holding Dr. Werner Lanthaler is the founder and CEO of Wlanholding, an investment company focused on driving innovations and sustainable growth in cutting-edge technologies. With over 20 years of management experience in the biotech and pharmaceutical sectors, Dr. Lanthaler supports visionary entrepreneurs in transforming innovative business ideas into scalable, successful organizations. As CEO of Evotec SE, he led the company through significant global growth. Prior to that, as CFO of Intercell AG, he was instrumental in establishing Austria’s first Biotech IPO and several product approvals. Dr. Lanthaler brings an extensive network, top class expertise in due diligence and a hands-on approach to building all aspects of a business.
He is the chairman in leading high-tech companies, including Fair Journey Biologics (Portugal), HAL Allergy (Netherlands), aTenstion.life (Austria), OncoDesignServices (France), and Proxygen (Austria).
His career is further supported by a strong academic background, including a PhD in Business Administration and an MPA from Havard Universit.
Recent key investments of Wlanholding include Proxygen GmbH, Cerabyte GmbH, Solgate GmbH, Planet Pure GmbH, Cyment GmbH, Pirche GmbH and Pexxes GmbH.
